Research graph
References from Intraoperative multi-layer perceptron-based artificial intelligence-assisted pure-vision and hyperspectral imaging reclassifies sleeve-resection candidates as eligible for lobectomy after neoadjuvant chemoimmunotherapy: A multicenter retrospective cohort and prospective exploratory study. Local targets link to admitted publications; unresolved targets remain external evidence.
Sleeve lobectomy in patients with non-small cell lung cancer: A report from the European Society of Thoracic Surgery database 2021
10.1093/ejcts/ezac502 · 2022 · External reference
For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?
10.21037/jtd.2016.04.60 · 2016 · External reference
Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer
10.1093/ejcts/ezae300 · 2024 · External reference
Evolution of a lung-sparing strategy with sleeve lobectomy and induction therapy for non-small cell lung cancer: 20-year experience at a single institution
10.1007/s00268-015-3330-z · 2016 · External reference
Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer
10.1016/j.jtcvs.2020.02.079 · 2021 · External reference
Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer
10.1056/nejmoa2202170 · 2022 · External reference
Extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer
10.1016/j.athoracsur.2025.03.033 · 2025 · External reference
Perioperative outcomes of video-assisted thoracoscopic surgery versus open thoracotomy after neoadjuvant chemoimmunotherapy in resectable NSCLC
2022 · External reference
Routine intraoperative frozen section analysis of bronchial margins is of limited utility in lung cancer resection
10.1016/j.athoracsur.2012.12.016 · 2013 · External reference
Residual disease at the bronchial stump after curative resection for lung cancer
10.1016/j.ejcts.2007.04.003 · 2007 · External reference
International association for the study of lung cancer study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy
10.1016/j.jtho.2023.07.017 · 2023 · External reference
Artificial intelligence-powered precision: Unveiling the tumor microenvironment for a new frontier in personalized cancer therapy
10.1016/j.imed.2025.02.001 · 2025 · External reference
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
10.1200/jco-24-02239 · 2025 · External reference
Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
10.1016/j.lungcan.2022.01.019 · 2022 · External reference
A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer
10.1002/cam4.4889 · 2023 · External reference
Transformers in medical image analysis
10.1016/j.imed.2022.07.002 · 2023 · External reference
A pulmonary nodule is worth 8×8×8 words: Computed tomography-based 3D vision transformer predicts early-stage high-grade lung adenocarcinoma of micropapillary and/or solid subtypes
10.1016/j.imed.2025.11.001 · 2025 · External reference
Medical hyperspectral imaging: a review
10.1117/1.jbo.19.1.010901 · 2014 · External reference
Medical artificial intelligence and the black box problem: A view based on the ethical principle of “do no harm.”
10.1016/j.imed.2023.08.001 · 2024 · External reference
